VasoDynamics initiates NG13 optimisation development with key appointment Gallery VasoDynamics initiates NG13 optimisation development with key appointment By Chloe Atkinson|2024-12-05T11:09:11+00:00February 8th, 2024|Clinical Development, Corporate Development, News, NG13| Read More
Labour Shadow Health Team Visit Stevenage Bioscience Catalyst and Discuss VasoDynamics’ Technology Gallery Labour Shadow Health Team Visit Stevenage Bioscience Catalyst and Discuss VasoDynamics’ Technology By Bradley Shaw|2024-07-25T12:49:03+00:00February 7th, 2024|News| Read More
NG11-2 Phase-Ib Dose Escalation Clinical Study Progresses to Final Dose Level Gallery NG11-2 Phase-Ib Dose Escalation Clinical Study Progresses to Final Dose Level By Chloe Atkinson|2024-11-13T12:58:52+00:00December 21st, 2023|Clinical Development, News, NG12| Read More
VasoDynamics files global patent (PCT) for the methods to select patients for the clinical studies on radiation-induced oral mucositis Gallery VasoDynamics files global patent (PCT) for the methods to select patients for the clinical studies on radiation-induced oral mucositis By Chloe Atkinson|2024-07-25T12:49:04+00:00November 7th, 2023|News| Read More
NG11-2 Phase Ib Dose Escalation Clinical Study Progressing through Dose Levels Gallery NG11-2 Phase Ib Dose Escalation Clinical Study Progressing through Dose Levels By Chloe Atkinson|2024-11-13T12:59:13+00:00October 16th, 2023|Clinical Development, News, NG11| Read More
VasoDynamics strengthens management team with key appointments Gallery VasoDynamics strengthens management team with key appointments By Chloe Atkinson|2024-11-13T12:59:24+00:00August 1st, 2023|Corporate Development, News| Read More
First dose cohort completed and enrolment to second dose cohort commenced in NG11-2 Phase-Ib clinical trial Gallery First dose cohort completed and enrolment to second dose cohort commenced in NG11-2 Phase-Ib clinical trial By Chloe Atkinson|2024-11-13T14:09:14+00:00July 28th, 2023|Clinical Development, News, NG11| Read More
First patient dosed for the first week in NG11-2 Phase Ib clinical trial Gallery First patient dosed for the first week in NG11-2 Phase Ib clinical trial By Chloe Atkinson|2024-11-13T12:59:46+00:00May 26th, 2023|Clinical Development, News, NG11| Read More
First patient enrolled in NG11-2 Phase Ib clinical trial Gallery First patient enrolled in NG11-2 Phase Ib clinical trial By Chloe Atkinson|2024-11-13T13:00:15+00:00May 8th, 2023|Clinical Development, News, NG11| Read More
VasoDynamics Receives Global Health & Pharma Biotechnology 2023 Award Gallery VasoDynamics Receives Global Health & Pharma Biotechnology 2023 Award By Chloe Atkinson|2024-07-25T13:04:56+00:00April 12th, 2023|News| Read More
